Wu Qing

Wu Qing is a Senior Scientist at AstraZeneca, currently engaged in advanced research in the field. They earned a Doctor of Philosophy in Computational Biology from Brown University, where they developed a novel deep learning model for autism spectrum disorders risk prediction. Wu previously worked as a Research Scholar at UMass Dartmouth, focusing on cancer sensor development, and as a Research Assistant at Augusta University, where they investigated the efficacy of clinical trial drugs in lymphoma cells. Additionally, they hold a Master of Science in Bioinformatics from Northeastern University and another in Biochemistry and Molecular Biology from Shanghai Jiao Tong University.